Basic Materials
Ellenbarrie Industrial Gases Limited (ELLEN) pulls back from breakout highs, falls 5%
Ellenbarrie Industrial Gases Limited (NSE: ELLEN) stock price drops 5% intraday to ₹256.9, exhibiting pressure following a recent breakout..
Ellenbarrie Industrial Gases Limited (ELLEN) fell -5% today, nearing its 6-month support trendline at ₹259. The decline is technical, with no recent NSE filing or news catalyst. The stock is part of the Basic Materials sector, specifically in the Chemicals sub-sector. Today’s move appears company-specific, as broader sector momentum remains mixed.
Technical setup — trendlines & DMA
Currently, ELLEN is trading just below its 6-month support trendline, which ends at ₹259. The stock has broken out from this support, indicating a potential bounce. Resistance is seen at ₹267.36, where the stock is currently trading below by 4.07%. The 50-DMA is at ₹273.4, slightly below the 200-DMA at ₹296.3, suggesting a bearish trend. ELLEN is currently in the lower third of its 52-week range, indicating that much of the downside may already be priced in.
Snapshot: ₹256.90 on 2026-07-30 (chart frozen at publication)
Fundamentals & business context
With a PE of 36.0, ELLEN appears to be priced for growth, especially given its robust profit margin of 30.6% and a 5-year revenue CAGR of 9.3%. The market seems to be pricing in the company’s strong profit growth of 25.3% over the past five years. Institutional ownership stands at 13.2%, indicating a moderate level of confidence from smart money. There is no NSE catalyst today, and the move is purely technical.
Algorithmic scorecard
The overall scorecard reflects a balanced view, with strong fundamental signals offset by weaker technical indicators. The strongest fundamental signals are the excellent profit margin of 30.6% and the consistent revenue growth, which points to a stable and profitable business. On the technical side, the bullish sentiment over the last 30 days, with a higher average volume on up days, suggests systematic accumulation. The weakest signals are the bearish trend indicated by the 50-DMA being below the 200-DMA and the stock’s poor performance over the last year, down 50.2%, which highlights the need for caution.
Company outlook
Management has outlined an ambitious roadmap for FY27, targeting a 20% CAGR in revenue growth over the next 2 to 3 years and aiming for a 40% EBITDA margin in the medium term. The growth will be driven by capacity additions and improved operating leverage, particularly if argon prices continue to recover. Key initiatives include the efficient ramp-up of Uluberia 2, the commissioning of the East India on-site plant expected next month, and expanding into new markets in north India and west-central India.
Get all details on ELLEN — P&L, peers, shareholding and more on TradeAlone.
Basic Materials
Privi Speciality Chemicals Limited (priviscl) Q2 FY27: Prosperity with Orderliness
Privi Speciality Chemicals Limited (PRIVISCL) reports strong Q2 FY27 results with 13.9% revenue growth, 16.7% EBITDA, and 24.6% net profit.
Privi Speciality Chemicals Limited (PRIVISCL) has reported robust Q2 FY27 results, showcasing a strong financial performance under the theme of ‘Prosperity With Orderliness’. The company delivered Rs 773.16 Cr of total income, marking a 13.90% year-on-year growth. EBITDA surged by 16.66% to Rs 212.49 Cr, while net profit rose by 24.61% to Rs 117.03 Cr. These impressive figures reflect the resilience of Privi’s business model and disciplined execution.
Financial Highlights
The company’s strategic vision and disciplined execution have led to significant financial improvements. EBITDA margin improved by 65 basis points to 27.48%, and the return on capital employed (ROCE) increased by 216 basis points to 24.30%. The return on equity (ROE) also saw a substantial improvement of 134 basis points to 26.34%. Moreover, the net debt to EBITDA ratio improved by 37.9% to 0.51, and the net debt to equity ratio decreased by 32.1% to 1.07.
Growth Strategy
Privi Speciality Chemicals Limited remains well-positioned for future growth. The company’s diversified geographic presence has supported stability across markets, and the expansion projects are progressing as planned. New products are expected to expand the addressable market and contribute meaningfully to growth in the coming years. With a strong balance sheet, healthy cash flows, and a clear strategic roadmap, Privi Speciality Chemicals Limited is poised for continued prosperity.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Privi Speciality Chemicals Limited
Privi Speciality Chemicals Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.
Privi posts a 6.3% three-month gain, but softens in the last few weeks. The PEG of 0.30 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. The business compounds revenue at 16.6% and profits at 145.2% CAGR. That is strong double-digit growth on both counts. The stock gives back 2.7% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Both the business and the stock move in the right direction. Revenue grows at 16.6%, profits at 145.2%, and the PEG sits at 0.30 — below its growth rate. That combination is rare. Check Fundamentals of Privi Speciality Chemicals Limited.
Agricultural Inputs
Pi Industries Limited Unveils Pioxaniliprole, India’s First Indigenously Discovered Insecticide
PI Industries Limited (PIIND) unveils Pioxaniliprole, India’s first indigenously discovered insecticide, marking a significant milestone in agricultural inno.
PI Industries Limited (PIIND) has made a groundbreaking announcement today, unveiling Pioxaniliprole, India’s first indigenously discovered insecticide. This decade-long research breakthrough marks a defining milestone in India’s ability to originate world-class agricultural science and proprietary innovation.
A Milestone in Agricultural Innovation
Developed through more than a decade of original research, Pioxaniliprole demonstrates the country’s growing capability to originate novel scientific discoveries and create proprietary intellectual property. This achievement strengthens PI’s ambition to build a global, innovation-led Life Sciences company, creating original science and intellectual property from India for the world.
Significance Beyond a Single Molecule
The significance of Pioxaniliprole extends beyond a single molecule. It is the first outcome of a broader innovation pipeline at PI, spanning chemistry, biology, and biochemical solutions. Together, these mark an important step in India’s journey towards greater scientific self-reliance, strengthening indigenous research capabilities and creating opportunities for Indian-origin agricultural innovation to address challenges of global relevance.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of PI Industries Limited
PI Industries Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.
PI drops 16.5% over three months and trades near its 52-week lows. The PEG stands at 11.88 — severely stretched. Any earnings miss could trigger a sharp de-rating. Revenue grows at 1.1% CAGR. The company generates cash but does not compound aggressively. The stock sits at 5% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 1.1% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of PI Industries Limited.
Basic Materials
Kotyark Industries Limited (kotyark) Q2 FY27: PAT Surges 148% Yoy to ₹6.24 Crore; Ebitda Margin Expands to 20.72%
Kotyark Industries Limited (NSE: KOTYARK) announced Q2 FY27 results with a 148% YoY surge in PAT to ₹6.24 Crore, and a 20.72% EBITDA margin.
Kotyark Industries Limited (NSE: KOTYARK), a biodiesel manufacturing company, announced its unaudited financial results for the quarter and half year ended September 30, 2026 (Q2 & H1 FY27), as approved by the Board of Directors at its meeting held on October 28, 2026. This release discusses consolidated performance. In Q2 FY27, consolidated revenue from operations was ₹61.27 Crore, 5.5% lower than Q2 FY26, while EBITDA rose 50.7% to ₹12.70 Crore and Profit After Tax (PAT) increased 147.6% to ₹6.24 Crore. The EBITDA margin improved to 20.72% of total income from 12.99%, and the PAT margin to 10.18% from 3.88%. For H1 FY27, total revenue grew 4.0% to ₹153.28 Crore and PAT grew 61.9% to ₹10.70 Crore.
Q2 FY27 Consolidated Financial Results
In Q2 FY27, consolidated financial results showed a significant improvement in profitability. Despite a 5.5% year-on-year decline in revenue, EBITDA increased 50.7% to ₹12.70 Crore and Profit After Tax (PAT) rose 147.6% to ₹6.24 Crore. Total expenses declined 14.2% to ₹52.93 Crore from ₹61.71 Crore in the corresponding quarter last year.
H1 FY27 Consolidated Financial Results
For H1 FY27, revenue from operations grew 4.0% to ₹153.25 Crore, EBITDA increased 30.2% to ₹24.41 Crore and PAT rose 61.9% to ₹10.70 Crore, reflecting improved profitability over the half year. Looking ahead, Kotyark Industries Limited is targeting revenue CAGR of 25 – 30% over the next three years, with an EBITDA margin aspiration of 18 -22%. Growth is expected to be supported by higher biodiesel volumes, improved plant utilisation, operating efficiencies, integrated sourcing advantages and a greater contribution from value added products.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Kotyark Industries Limited
Kotyark Industries Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.
Kotyark falls 8.7% over three months and has not found a floor yet. Thin margins at 6.1% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue consistency is the one bright spot — zero dips in five years shows operational resilience. The stock holds at 50% of its 52-week range with RSI at 44. In other words, neither side has a clear edge right now. The stock rises -8.7% in three months on 34.1% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Kotyark Industries Limited.
-
Consumer Cyclical3 days agoSky GOLD and Diamonds Limited (NSE: Skygold) Q2 and H1 FY27: Revenue at Rs 4,403.45 Crore, PAT Up 111.9%
-
AWL3 days agoAwl Agri Business Limited (AWL) Delivers Strong Q2 FY27 Growth; Revenue Grows 26% to INR 22,202 Crore with Operating Ebitda Up 11% Yoy
-
Consumer Cyclical3 days agoKanpur Plastipack Limited (NSE: Kanprpla) Q2 FY27: Revenue, Ebitda & PAT Surge
-
Consumer Cyclical3 days agoHuhtamaki India Limited Q3 FY26: Net Sales Surge 23.7%, EBIT Up 18%
-
DYCL3 days agoDynamic Cables Limited (dycl) Scaling with Strength: Q2 FY27 Results Show Strong Growth
-
ACUTAAS3 days agoAcutaas Chemicals Limited (acutaas) Q2 & H1 FY27 Results: Revenue Up 42.7% Yoy, PAT Surges 71.4%
-
Industrials3 days agoNavkar Corporation Limited Announces Q2 FY27 Results: Revenue Up 15%, Ebitda Surges 20%
-
Auto Parts3 days agoSchaeffler India Limited (NSE: Schaeffler) Q3 FY26: Double-digit Growth Across Domestic and Export Businesses